Angelini Pharma Expands Brain Health Portfolio with Sovargen Tie-Up
ROME Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean biotechnology company, announced today that they signed an exclusive global option agreement for the development and…


